The Weight Management segment represents approximately 31.2% of market revenue in 2025 but is growing significantly faster at a projected CAGR of 19.4% versus 14.8% for Diabetes Treatment, driven by Wegovy's expanding global approvals and the SELECT trial's cardiovascular label update
In the space of 9 months, I have shed 30kg and my BMI is of a normal weight for the first time in my adult life
These models closely mimic human metabolic dysfunction and highlight the dysregulated interplay between leptin and adiponectin in diet-induced obesity 43
Remenyi J, Hunter CJ, Cole C, Ando H, Impey S, Monk CE, Martin KJ, Barton GJ, Hutvagner G, Arthur JS
The prescription medications do so by simulating GLP-1 and putting your body's GLP-1 receptors into constant prolonged activation
The FDA's pharmacovigilance database has not identified a safety signal linking these two drug classes when used together